- GlobeNewswire•7 hours ago
IRVINE, Calif., Oct. 25, 2016-- Endologix, Inc., developer and marketer of innovative treatments for aortic disorders, announced the appointment of Matthew Thompson, M.D., as Chief Medical Officer effective ...
- GlobeNewswire•yesterdayEndologix Announces Release Date for Third Quarter 2016 Financial Results and Details of 2016 Investor Meeting
IRVINE, Calif., Oct. 24, 2016-- Endologix, Inc., developer and marketer of innovative treatments for aortic disorders, announced today details relating to the release of its third quarter 2016 financial ...
Endologix Inc. (ELGX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||11.88 x 2200|
|Ask||11.89 x 800|
|Day's Range||11.78 - 12.50|
|52wk Range||6.51 - 14.50|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-6.24|
|Avg Vol (3m)||878,269|
|Dividend & Yield||N/A (N/A)|